AMGEN Inc.

NASDAQ:AMGN   4:00:00 PM EDT
221.25
+0.03 (+0.01%)
7:36:46 PM EDT: $221.25 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)118.22B
Current PE14.93
Forward PE 12.28
2yr Forward PE 11.46
See more stats
Estimates Current Quarter
Revenue$6.69 Billion
Adjusted EPS$4.48
See more estimates
10-Day MA$220.77
50-Day MA$233.43
200-Day MA$244.58
See more pivots

AMGEN Inc. Stock, NASDAQ:AMGN

One Amgen Center Drive, Thousand Oaks, California 91320-1799
United States of America
Phone: +1.805.447.1000
Number of Employees: 25200

Description

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.